Switching CF patients from previous pancreatic enzyme replacement therapy to ZENPEP™ (pancrelipase delayed-release capsules) improves symptom control of exocrine pancreatic insufficiency (EPI)
Autor: | Heubi, J.E., Straforini, C., Thieroff-Ekerdt, R. |
---|---|
Zdroj: | In Journal of Cystic Fibrosis 2010 9 Supplement 1:S77-S77 |
Databáze: | ScienceDirect |
Externí odkaz: |